Search research articles
Contact Us
Filters
Showing results (221-230 of 323) with videos related to
Page
of 33
Sort By:
Infection and Immunity
|
January 7, 2015
Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera
Crystal N Ellis, Regina C LaRocque, Taher Uddin, et al.
The Journal of Infectious Diseases
|
February 28, 2015
Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection
Louise C Ivers, Richelle C Charles, Isabelle J Hilaire, et al.
Nature Genetics
|
June 27, 2018
Defining endemic cholera at three levels of spatiotemporal resolution within Bangladesh
Daryl Domman, Fahima Chowdhury, Ashraful I Khan, et al.
Clinical and Vaccine Immunology : CVI
|
June 24, 2011
Comparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh
Daniel T Leung, Mohammad Arif Rahman, M Mohasin, et al.
The Journal of Infectious Diseases
|
September 9, 2011
LPLUNC1 modulates innate immune responses to Vibrio cholerae
Ok S Shin, Taher Uddin, Robert Citorik, et al.
Clinical and Vaccine Immunology : CVI
|
March 24, 2012
Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh
Daniel T Leung, Mohammad Arif Rahman, M Mohasin, et al.
Scientific Reports
|
October 25, 2016
Immune Responses to an Oral Cholera Vaccine in Internally Displaced Persons in South Sudan
Anita S Iyer, Malika Bouhenia, John Rumunu, et al.
Plos Neglected Tropical Diseases
|
May 3, 2014
Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti
Richelle C Charles, Isabelle J Hilaire, Leslie M Mayo-Smith, et al.
Msphere
|
August 30, 2023
Comparison of O-specific polysaccharide responses in patients following infection with <i>Vibrio cholerae</i> O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh
M Hasanul Kaisar, Meagan Kelly, Mohammad Kamruzzaman, et al.
Cell
|
November 18, 2020
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality
Tomer Zohar, Carolin Loos, Stephanie Fischinger, et al.
Page
of 33
Search research articles
Search
Showing results (221-230 of 323) with videos related to
Sort By:
Page
of 33
Infection and Immunity
|
January 7, 2015
Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera
Crystal N Ellis, Regina C LaRocque, Taher Uddin, et al.
The Journal of Infectious Diseases
|
February 28, 2015
Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection
Louise C Ivers, Richelle C Charles, Isabelle J Hilaire, et al.
Nature Genetics
|
June 27, 2018
Defining endemic cholera at three levels of spatiotemporal resolution within Bangladesh
Daryl Domman, Fahima Chowdhury, Ashraful I Khan, et al.
Clinical and Vaccine Immunology : CVI
|
June 24, 2011
Comparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh
Daniel T Leung, Mohammad Arif Rahman, M Mohasin, et al.
The Journal of Infectious Diseases
|
September 9, 2011
LPLUNC1 modulates innate immune responses to Vibrio cholerae
Ok S Shin, Taher Uddin, Robert Citorik, et al.
Clinical and Vaccine Immunology : CVI
|
March 24, 2012
Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh
Daniel T Leung, Mohammad Arif Rahman, M Mohasin, et al.
Scientific Reports
|
October 25, 2016
Immune Responses to an Oral Cholera Vaccine in Internally Displaced Persons in South Sudan
Anita S Iyer, Malika Bouhenia, John Rumunu, et al.
Plos Neglected Tropical Diseases
|
May 3, 2014
Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti
Richelle C Charles, Isabelle J Hilaire, Leslie M Mayo-Smith, et al.
Msphere
|
August 30, 2023
Comparison of O-specific polysaccharide responses in patients following infection with <i>Vibrio cholerae</i> O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh
M Hasanul Kaisar, Meagan Kelly, Mohammad Kamruzzaman, et al.
Cell
|
November 18, 2020
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality
Tomer Zohar, Carolin Loos, Stephanie Fischinger, et al.
Page
of 33